Publication:
Effects of 18-month Vildagliptin Treatment on Portal Vein Pressure and Hepatosteatosis

Loading...
Thumbnail Image
Date
2019-10-01T00:00:00Z
Authors
KARATOPRAK, CUMALİ
KISKAÇ, MUHARREM
ZORLU, MEHMET
ÇAKIRCA, MUSTAFA
Aydin, Sinem
Ozkan, Tuba
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue

Metrics

Search on Google Scholar

Abstract
Objective: Patients with type 2 diabetes have an increased tendency to develop hepatosteatosis. The effects of drugs used to treat diabetes on the liver, regardless of the disease, are unknown.The aim of this study was to investigate the effects of vildagliptin, a dipeptidyl peptidase-4 inhibitor, on the portal vein pressure and hepatosteatosis in patients with type 2 diabetes in the 18 months of follow-up.
Description
Keywords
Citation
KARATOPRAK C., Kilicarslan R., ÇAKIRCA M., Aydin S., Ozkan T., ZORLU M., KISKAÇ M., -Effects of 18-month Vildagliptin Treatment on Portal Vein Pressure and Hepatosteatosis-, BEZMIALEM SCIENCE, cilt.7, ss.317-321, 2019
Page Views

0

File Downloads

0

Sustainable Development Goals